Ahmet BOZKURT, Gönül KEMİKLER, Hediye ACUN BUCHT

Dosimetric Accuracy of an HDR Brachytherapy Treatment Planning System for Different Irradiation Lengths with Monte Carlo Simulation

OBJECTIVEThe purpose of the present study was to verify calculated dose rate profiles of Ir-192 for four differentirradiation lengths and various numbers of dwell positions by using treatment planning system (TPS)calculations and Monte Carlo (MC) simulations.METHODSDose rate profiles per air-kerma strength in μGy m2/h (abbreviated as U) were calculated on transverseaxis for irradiation lengths of 2, 3, 4, and 5 cm by Nucletron Oncentra TPS. The same irradiation scenarios were simulated with Monte Carlo N-Particle (MCNP) Transport Code. The MC and TPS calculateddose rate profiles were compared for all settings.RESULTSThe difference between the calculated dose rate profiles by MC and TPS was found within 2% at aninterval of 2 mm–8 cm away from the source for all irradiation lengths. The largest discrepancy of 5.2%was computed at a distance of 10 cm from the source for 5 cm irradiation length.CONCLUSIONThere is a good consistency between the calculated dose rate profiles by MCNP and Oncentra TPS. Thedeviation between the calculated dose rate values slightly increases as the distance from the source center increases >5 cm from the source, and its quantity depends on the number of dwell positions.

PDF

___

1. Suntharalingam N, Podgorsak EB, Tölli H. Brachytherapy: Physical and Clinical Aspects. In: Podgorsak EB, Editor. Radiation Oncology Physics: A Handbook for Teachers and Students. Vienna: International Atomic Energy Agency; 2005. p. 454.
2. Angelopoulos A, Baras P, Sakelliou L, Karaiskos P, Sandilos P. Monte Carlo dosimetry of a new 192Ir high dose rate brachytherapy source. Med Phys 2000;27(11):2521–7.
3. Strohmmaier S, Zwierzchowski G. Comparison of 60Co and 192Ir sources ın HDR brachytherapy. J Contemp Brachytherapy 2011;3(4):199–208.
4. Rivard MJ, Venselaar JLM, Beaulieu L. The evolution of brachytherapy treatment planning. Med Phys 2009;36(6):2136–53.
5. Rivard MJ, Coursey BM, DeWerd LA, Hanson WF, Hug MS, Ibbott GS, et al. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. Med Phys 2004;31(3):633–74.
6. Perez-Calatayud J, Ballester F, Serrano-Andres MA, Puchades V, Lluch JL, Limami Y, et al. Dosimetry characteristics of the Plus and 12i GammaMed PDR 192 Ir sources. Med Phys 2001;28(12):2576–85.
7. Medich DC, Munro JJ 3rd. Monte Carlo characterization of the M-19 high dose rate Iridium-192 brachytherapy source. Med Phys 2007;34(6):1999–2006.
8. Perez-Calatayud J, Cabanero DG, Ballaster FB. Monte Carlo Application in Brachytherapy Dosimetry. In: Lemoigne Y, Caner A, editors. Radiotherapy and Brachytherapy. Netherlands: Springer; 2009. p. 239– 40.
9. De Boeck L, Belien J, Egyed W. Dose optimization in high-dose-rate brachytherapy: A literature review of quantitative models from 1990 to 2010. Oper Res Health Care 2014;3(2):80–90.
10.Giannouli S, Baltas D, Milickovic N, Lahanas M, Kolotas C, Zamboglou Z, et al. Autoactivation of source dwell positions for HDR brachytherapy treatment planning. Med Phys 2000;27(11):2517–20.
11.Mowlavi AA, Cupardo F, Severgnini M. Monte Carlo and experimental relative dose determination for an Iridium-192 source in water phantom. Iran J Radiat Res 2008;6(1):37–42.
12.Lymperopoulou G, Pantelis E, Papagiannis P, RozakiMavrouli H, Sakelliou L, Baltas D, et al. A Monte Carlo dosimetry study of vaginal 192Ir brachytherapy applications with a shielded cylindrical applicator set. Med Phys 2004;31(11):3080–6.
13.Mosleh Shirazi MA, Faghihi R, Siavashpour Z, Nedaie HA, Mehdizadeh S, Sina S. Independent evaluation of an in-house brachytherapy treatment planning system using simulation, measurement and calculation methods. J Appl Clin Med Phys 2012;13(2):3687.
14.Naseri A, Mesbahi A. Application of Monte Carlo calculations for validation of a treatment planning system in high dose rate brachytherapy. Rep Pract Oncol Radiother 2009;14(6):200–4.
15.Bahreyni Toossi MT, Abdollahi M, Ghorbani M. A Monte Carlo study on dose distribution validation of GZP6 (60)Co stepping source, Rep Pract Oncol Radiother 2013;18(2):112–6.
16.Hadad K, Zohrevand M, Faghihi R, Sedighi Pashaki A. Accuracy evaluation of OncentraTM TPS in HDR Brachytherapy of Nasopharynx cancer using EGSnrc Monte Carlo code. J Biomed Phys Eng 2015;5(1):25–30.
17.Briesmeister JF. MCNPTM – A general Monte Carlo N-particle transport code, Version 4C. Los Alamos National Laboratory Report. Available at: https:// permalink.lanl.gov/object/tr?what=info:lanl-repo/lareport/LA-13709-M. Accessed February 16, 2019.
18.Ballester F, Puchades V, Lluch JL, Serrano-Andres MA, Limami Y, Perez-Calatayud J, et al. Technical note: Monte-Carlo dosimetry of the HDR 12i and Plus 192Ir sources. Med Phys 2001;28(12):2586–91.
19.Ballester F, Perez-Calatayud J, Puchades V, Lluch JL, Serrano-Andres MA, Limami Y, et al. Monte Carlo dosimetry of the Buchler high dose rate 192Ir source. Phys Med Biol 2001;46(3):N79–90.
20.Granero D, Vijande J, Ballester F, Rivard MJ. Dosimetry revisited for the HDR 192Ir brachytherapy source model mHDR-v2. Med Phys 2011;38(1):487–94.
21.Almansa Lopez JF, Torres Donaire J, Guerrero Alcalde R. Monte Carlo dosimetry of the most commonly used 192Ir high dose rate brachytherapy sources. Rev Fis Med 2011;12(3):159–68.
22.Wang R, Li XA. Dose characterization in the nearsource region for two high dose rate brachytherapy sources. Med Phys 2002;29(8);1678–86.
23.Chandola RM, Tiwari S, Kowar MK, Choudhary V. Monte Carlo and experimental dosimetric study of the mHDR-v2 brachytherapy source. J Cancer Res Ther 2010;6(4):421–6.
24.Daskalov GM, Löffler E, Williamson JF. Monte Carloaided dosimetry of a new high dose-rate brachytherapy source. Med Phys 1998;25(11):2200–8.